These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30408128)

  • 1. A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer.
    Ashton JR; Gottlin EB; Patz EF; West JL; Badea CT
    PLoS One; 2018; 13(11):e0206950. PubMed ID: 30408128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors.
    Ping Li W; Meyer LA; Capretto DA; Sherman CD; Anderson CJ
    Cancer Biother Radiopharm; 2008 Apr; 23(2):158-71. PubMed ID: 18454685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer.
    Yamaguchi A; Achmad A; Hanaoka H; Heryanto YD; Bhattarai A; Ratianto ; Khongorzul E; Shintawati R; Kartamihardja AAP; Kanai A; Sugo Y; S Ishioka N; Higuchi T; Tsushima Y
    BMC Cancer; 2019 Oct; 19(1):1000. PubMed ID: 31651282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.
    Tseng SH; Chou MY; Chu IM
    Int J Nanomedicine; 2015; 10():3663-85. PubMed ID: 26056447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.
    Khan JA; Kudgus RA; Szabolcs A; Dutta S; Wang E; Cao S; Curran GL; Shah V; Curley S; Mukhopadhyay D; Robertson JD; Bhattacharya R; Mukherjee P
    PLoS One; 2011; 6(6):e20347. PubMed ID: 21738572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.
    Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F
    Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model.
    Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin MH; Wang HE
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3180-5. PubMed ID: 23628334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective uptake and imaging of aptamer- and antibody-conjugated hollow nanospheres targeted to epidermal growth factor receptors overexpressed in head and neck cancer.
    Melancon MP; Zhou M; Zhang R; Xiong C; Allen P; Wen X; Huang Q; Wallace M; Myers JN; Stafford RJ; Liang D; Ellington AD; Li C
    ACS Nano; 2014 May; 8(5):4530-8. PubMed ID: 24754567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.
    Li W; Liu Z; Li C; Li N; Fang L; Chang J; Tan J
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):619-32. PubMed ID: 26573511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.
    Puvanakrishnan P; Diagaradjane P; Kazmi SM; Dunn AK; Krishnan S; Tunnell JW
    Lasers Surg Med; 2012 Apr; 44(4):310-7. PubMed ID: 22415634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.
    Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B
    Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The physicochemical and biological characterization of a 24-month-stored nanocomplex based on gold nanoparticles conjugated with cetuximab demonstrated long-term stability, EGFR affinity and cancer cell death due to apoptosis.
    Andrade LM; Martins EMN; Versiani AF; Reis DS; da Fonseca FG; Souza IP; Paniago RM; Pereira-Maia E; Ladeira LO
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110203. PubMed ID: 31761220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembled multifunctional nanotheranostics loading GEM for targeted lung cancer therapy.
    Tang J; Zheng F; Zhao J; Zhao J
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110786. PubMed ID: 32409023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations.
    Perez-Torres M; Guix M; Gonzalez A; Arteaga CL
    J Biol Chem; 2006 Dec; 281(52):40183-92. PubMed ID: 17082181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
    Johns TG; Stockert E; Ritter G; Jungbluth AA; Huang HJ; Cavenee WK; Smyth FE; Hall CM; Watson N; Nice EC; Gullick WJ; Old LJ; Burgess AW; Scott AM
    Int J Cancer; 2002 Mar; 98(3):398-408. PubMed ID: 11920591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
    Patra CR; Bhattacharya R; Wang E; Katarya A; Lau JS; Dutta S; Muders M; Wang S; Buhrow SA; Safgren SL; Yaszemski MJ; Reid JM; Ames MM; Mukherjee P; Mukhopadhyay D
    Cancer Res; 2008 Mar; 68(6):1970-8. PubMed ID: 18339879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.
    Bhattacharyya S; Bhattacharya R; Curley S; McNiven MA; Mukherjee P
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14541-6. PubMed ID: 20679244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors.
    Lara P; Palma-Florez S; Salas-Huenuleo E; Polakovicova I; Guerrero S; Lobos-Gonzalez L; Campos A; Muñoz L; Jorquera-Cordero C; Varas-Godoy M; Cancino J; Arias E; Villegas J; Cruz LJ; Albericio F; Araya E; Corvalan AH; Quest AFG; Kogan MJ
    J Nanobiotechnology; 2020 Jan; 18(1):20. PubMed ID: 31973696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
    Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
    Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.
    Qian Y; Qiu M; Wu Q; Tian Y; Zhang Y; Gu N; Li S; Xu L; Yin R
    Sci Rep; 2014 Dec; 4():7490. PubMed ID: 25502402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.